HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
Enteroviruses such as coxsackievirus B4 (CVB4) are proposed as possible environmental triggers or accelerants of the autoimmune process that leads to type 1 diabetes mellitus. One putative mechanism to account for this association is mimicry between virus components and islet autoantigens. Particular interest has focused on the CVB4 non-structural protein P2C, which we previously showed to be a major target of the effector memory anti-CVB4 CD4 T-cell response, and which harbours a region of sequence similarity with the islet autoantigen, glutamic acid decarboxylase (GAD65). Since several distinct human leucocyte antigen (HLA) Class II molecules are associated with development of type 1 diabetes, we hypothesized that for functional mimicry to be important, any potential region(s) of mimicry in P2C should bind to each of these susceptibility molecules. In the present study therefore we examined the affinity of 20-mer overlapping P2C peptides for soluble HLA-DR4, -DR3, -DQ2 and -DQ8. We identified one discrete region of P2C with high binding affinities for all of these HLA Class II molecules. Moreover, the binding affinity of P2C peptides was significantly correlated between HLA molecules present on the same susceptibility haplotype (e.g. DR4 and DQ8, P =0.0076; DR3 and DQ2 P = 0.002). We conclude that possession of these haplotypes favours restricted presentation of viral epitopes, and speculate that this could promote the potential for mimicry between microbial proteins and islet autoantigens.
Ellis
Richard J
RJ
Department of Immunobiology, Guy's King's & St Thomas' School of Medicine, King's College London, Guy's Hospital, United Kingdom. richard.ellis@kcl.ac.uk
Varela-Calvino
Ruben
R
Tree
Timothy I M
TI
Peakman
Mark
M
D000595:Amino Acid Sequence; D000915:Antibody Affinity / Q000276:immunology; D017951:Antigen Presentation / Q000276:immunology; D000956:Antigens, Viral / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology*; D020022:Genetic Predisposition to Disease; D006681:HLA-D Antigens / Q000378:metabolism*; D006683:HLA-DQ Antigens / Q000378:metabolism; D015803:HLA-DR3 Antigen / Q000378:metabolism; D015804:HLA-DR4 Antigen / Q000378:metabolism; D006239:Haplotypes; D006801:Humans; D018716:Molecular Mimicry / Q000276:immunology; D008969:Molecular Sequence Data; D014764:Viral Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
D000956:Antigens, Viral; D006681:HLA-D Antigens; D006683:HLA-DQ Antigens; C053186:HLA-DQ2 antigen; C109756:HLA-DQ8 antigen; D015803:HLA-DR3 Antigen; D015804:HLA-DR4 Antigen; C089732:P2-C protein, Coxsackievirus; D014764:Viral Proteins